Latest Healthcare News

Page 73 of 150
Polynovo Limited reported a robust 23.3% increase in total revenue for FY25, driven by strong commercial sales growth across the US and international markets. The company is advancing its FDA PMA submission and expanding its global footprint amid strategic product development.
Ada Torres
Ada Torres
25 Aug 2025
PolyNovo Limited reported a robust 28.9% increase in group sales to A$118.6 million for FY25, alongside a 151% surge in net profit after tax to A$13.2 million, driven by strong U.S. growth and key regulatory approvals.
Ada Torres
Ada Torres
25 Aug 2025
InhaleRx Limited reported a widening half-year loss as it accelerates clinical trials for inhaled drug-device therapies, supported by a substantial $38.5 million funding facility.
Ada Torres
Ada Torres
25 Aug 2025
An independent in vivo study from the University of South Florida reveals ArtemiC™ significantly boosts survival and reduces inflammation in a severe viral model, reinforcing its promise as a novel immunomodulatory therapy.
Ada Torres
Ada Torres
25 Aug 2025
Neuren Pharmaceuticals has initiated the first US investigational site for its pivotal Phase 3 trial of NNZ-2591 targeting Phelan-McDermid syndrome, marking a significant milestone in addressing this rare neurodevelopmental disorder.
Ada Torres
Ada Torres
25 Aug 2025
Genetic Signatures reported a 63% revenue increase to $15.9 million in FY25, alongside a 28% reduction in underlying losses and a strategic shift in its automated diagnostics platform development.
Ada Torres
Ada Torres
25 Aug 2025
Genetic Signatures Limited reported a 63% revenue surge to $15.9 million in FY25, driven by strong Australian sales and progress in EMEA, while navigating a $20.1 million net loss and a strategic pivot towards partnerships for automated diagnostics.
Ada Torres
Ada Torres
25 Aug 2025
LTR Pharma’s SPONTAN nasal spray has achieved unanimous patient satisfaction in treating erectile dysfunction after prostate surgery, signaling a promising shift in therapy preferences.
Ada Torres
Ada Torres
25 Aug 2025
Regis Healthcare reported robust FY25 financial results, driven by increased occupancy, strategic acquisitions, and a strong balance sheet, positioning itself well ahead of the new Aged Care Act reforms.
Ada Torres
Ada Torres
25 Aug 2025
Regis Healthcare has reported a robust FY25 financial performance, marked by significant profit growth and strategic acquisitions, positioning itself for ambitious expansion in Australia’s aged care sector.
Ada Torres
Ada Torres
25 Aug 2025
Regis Healthcare delivered a robust FY25 performance with a 14.5% revenue increase and a dramatic turnaround to a $49 million net profit. The company is advancing growth through acquisitions and greenfield developments, positioning itself strongly ahead of upcoming sector reforms.
Ada Torres
Ada Torres
25 Aug 2025
Vitura Health Limited has announced its third fully franked dividend of 0.2 cents per share following a profitable FY2025, reinforcing its unique position in the medicinal cannabis sector. Shareholders are invited to participate in a discounted Dividend Reinvestment Plan.
Ada Torres
Ada Torres
25 Aug 2025